Cynapsus Therapeutics
About:
Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson’s disease.
Website: https://www.cynapsus.ca
Top Investors: OrbiMed, Aisling Capital, Venrock
Description:
Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson’s disease. The company specializes in the fields of healthcare, biotechnology, pharmaceutical, and therapeutics. It was founded in 2004 and headquartered in Toronto, Ontario.
Total Funding Amount:
$56.7M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Toronto, Ontario, Canada
Founded Date:
2004-01-01
Contact Email:
info(AT)cynapsus.ca
Founders:
Andrew Williams
Number of Employees:
11-50
Last Funding Date:
2015-03-31
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai